Tablets & Capsules Phthalates Article Authored by Safety Committee Working Group

News category: 
Thursday, April 17, 2014

Phthalate Enteric Polymer Excipients are not “Phthalates”: Safety of Enteric Polymers for Use as Pharmaceutical Excipients.

Members of the IPEC-Americas Safety Committee working group on Phthalates dispel some of the misunderstandings about excipients that contain the word "phthalate" in their name.

Article may be downloaded by clicking here

Safety Committee members have prepared a poster on this subject for the upcoming ExcipientFest Americas conference in Raleigh, NC. The poster will be on display during the conference's Poster Q&A Session on Monday April 28, 2014.

Below are references used for the article and the poster:

Albert A and Serjeant EP, The Determination of Ionization Constants, 2nd Ed., Chapman and Hall, London (1971).
Albro PW, Chapin RE, Corbett JT, Schroeder J, and Phelps JL. Mono-2-ethylhexyl phthalate, a metabolite of di-(2-ethylhexyl) phthalate, causally linked to testicular atrophy in rats. Toxicol Appl Pharmacol. 1989 Sep 1; 100(2):193-200.
Batt KJ, and Kotkoskie LA. (1999). An Evaluation of Genotoxicity Tests With Aquateric Aqueous Enteric Coating. International Journal of Toxicology 18(2):117-122.
Curto, KA and Thomas, JA. Comparative effects of diethylhexyl phthalate or monoethylhexyl phthalate on male mouse and rat reproductive organs. Toxicol Appl Pharmacol. 1982 Jan; 62(1):121-5.
EPA Phthalates Action Plan revised March 14, 2012: http://www.epa.gov/oppt/existingchemicals/pubs/actionplans/phthalates_ac...
FDA “Guidance for Industry—Limiting the Use of Certain Phthalates as Excipients in CDER-Regulated Products,” March 2012.
Fukasawa M and Obara S, (2003). Molecular Weight Determination of Hypromellose Phthalate (HPMCP) using Size Exclusion Chromatgraphy with a Multi-Laser Light Scattering Detector, Chem. Pharm. Bull. 51(11):1301-1306.
Gray TJ and Gangolli SD. Aspects of the testicular toxicity of phthalate esters. Environ Health Perspect. 1986 Mar; 65:229-235.
Hodge HC (1944). The Chronic Toxiciy of Cellulose Acetate Phthalate in Rats and Dogs. Journal of Pharmacology and Experimental Therapeutics 80(3):250-255.
Hodge HC, Forsyth HH, and Ramsey GH. (1944). Clinical Tests of Cellulose Acetate Phthalate as an Enteric Coating. Journal of Pharmacology and Experimental Therapeutics 80(3):241-249.
International Pharmaceutical Excipients Council of the Americas (IPEC-Americas). Correspondence: Defining “Phthalates”. Environmental Health Perspectives. 120(11), November 2012.
Ito R and Toida S. (1972), Studies on the Teratogenicity of a New Enteric Coating Material, Hydroxypropylmethylcellulose Phthalate (HPMCP) in Rats and Mice, J. Med. Soc. Toho, Japan, 19(5):453-461.
Kato T et al. (1982), Measurements of Molecular Weight and Molecular Weight Distribution for Watwer-Soluble Cellulose Derivatives Used in the Film Coating of Tablets, Kobunshi Ronbunshu, 39(4):293-298 (in Japanese).
Kelley KE, Hernández-Díaz S, Chaplin EL, Hauser R, and Mitchell AA. Identification of phthalates in medications and dietary supplement formulations in the United States and Canada. Environ Health Perspective. 2012 Mar; 120(3):379-84.
Kitagawa H et al. (1970). Acute, Subacute Toxicities of Hydroxypropylmethylcellulose phthalate, Pharmacometrics, 4(6):1017-1025.
Kitagawa, H et al (1973). Chronic Toxicity of Hydroxypropylmethylcellulose Phthalate in Rats, Pharmacometrics, 7(5), 689-701.
Kitgawa, H et al (1971). Absorption, Distribution and Excretion of Hydroxypropylmethylcellulose Phthalate in the Rat, Pharmacometrics, 5(1):1-4.
Kitagawa H et al (1974). Absorption, Distribution, Excretion and Metabolism of 14C-Hydroxypropylmethylcellulose Phthalate , Pharmacometrics, 8 (8):1123-1132.
Kotkoskie LA, Freeman C, and Palmieri MA. (1999). Subchronic Toxicity and Developmental Toxicity Studies in Rats With Aquateric Aqueous Enteric Coating. International Journal of Toxicology 18(2):109-116.
Malm, CJ, Emerson J., and Hiatt, GD. (1951). Cellulose acetate phthalate as an enteric coating material. J. Am. Pharm. Assoc. Am. Pharm. Assoc. 40(10):520-525.
Rowe RC, Sheskey PJ, Cook WG, and Fenton ME. Handbook of Pharmaceutical Excipients, 7th Edition: Pharmaceutical Press 2012.
Saillenfait AM, Payan JP, Fabry JP, Beydon D, Langonne I, Gallissot F, and Sabate JP. Assessment of the developmental toxicity, metabolism, and placental transfer of Di-n-butyl phthalate administered to pregnant rats. Toxicol Sci. 1998 Oct; 45(2):212-24.
Thomas JA, Curto KA, and Thomas MJ. MEHP/DEHP: gonadal toxicity and effects on rodent accessory sex organs. Environ Health Perspect. 1982 Nov; 45:85-8.
United States Pharmacopeial Convention, USP (2011). USP35/ NF30, 2012:
Williams DT and Blanchfield BJ. Retention, excretion and metabolism of phthalic acid administered orally to the rat, Bulletin of Environmental Contamination and Toxicology, (1974), 12 (1):109-112.
Woodward Research Corp. (1974). HP-50 and HP-55—Repeated Oral Administration of Each Test Material to Dogs for 53 Weeks—Final Report, Internal Document of Shin-Etsu Chemical.